Tom Lennox, Executive Director of Pelotonia, started with the inception of the project in June 2008. Prior to Pelotonia, Tom served as Vice President of Corporate Communications with Abercrombie and Fitch, where he managed the company’s global communications practices.
Tom is a cancer survivor and is leading Pelotonia, a grass roots bike tour, with one goal: to end cancer. Pelotonia raises money for innovative and life saving cancer research at The Ohio State University Comprehensive Cancer Center- James Cancer Hospital and Solove Research Institute. Driven by the passion of its cyclists and volunteers, and their family and friends, Pelotonia's annual cycling experience will be a place of hope, energy and determination. Leveraging NetJets' transformational gift, Pelotonia directs 100% of every dollar raised to research. It is a community of people coming together to chase down cancer and defeat it.
|
|
Michael Tweedle, PhD is Professor of Radiology, Chemistry and Pharmacy, and he holds the Stephanie Spielman Chair in Cancer Imaging in Radiology at the James Comprehensive Cancer Care Center. He heads the Wright Center Molecular Imaging Agents Laboratory, which is focused on creation and use of new MI agents for understanding of disease and its therapy.
Formerly, as President of Bracco Research USA, Dr. Tweedle was the chief executive and lead scientist, providing scientific and executive leadership in invention and commercialization of new imaging agents. He was educated at Knox College (BA Chemistry 1973), Rice University (PhD in Physical Chemistry 1978) and Stanford University (NRS Fellow with Nobel Professor Henry Taube 1977-1980).
|